WASHINGTON, Sept. 4 -- Food and Drug Administration has issued a notice called: Advancing Development of Botanical Drug Products; Request for Information.
The notice was published in the Federal Register on Sept. 4 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA or Agency) is opening a public docket to solicit comments on FDA's efforts to advance development of botanical drug products (BDPs). FDA is publishing this request for information to better understand stakeholders' perspectives on the state of BDP development in the United States, challenges encountered, and potential solutions to gathering the information required by the Federal Food, Drug,...